Expansion of Viral Load Testing and the Potential Impact on HIV Drug Resistance.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Raizes, Elliot; Hader, Shannon; Birx, Deborah
  • Source:
    Journal of Infectious Diseases (J INFECT DIS), 2017 Supplement; 216: S805-S807. (3p)
  • Publication Type:
    journal article - research
  • Language:
    English
  • Additional Information
    • Affiliation:
      Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Atlanta, Georgia
      Office of the US Global AIDS Coordinator, US Department of State, Washington, District of Columbia
    • Subject Terms:
    • Subject Terms:
    • Abstract:
      The US President's Emergency Plan for AIDS Relief (PEPFAR) supports aggressive scale-up of antiretroviral therapy (ART) in high-burden countries and across all genders and populations at risk toward global human immunodeficiency virus (HIV) epidemic control. PEPFAR recognizes the risk of HIV drug resistance (HIVDR) as a consequence of aggressive ART scale-up and is actively promoting 3 key steps to mitigate the impact of HIVDR: (1) routine access to routine viral load monitoring in all settings; (2) optimization of ART regimens; and (3) routine collection and analysis of HIVDR data to monitor the success of mitigation strategies. The transition to dolutegravir-based regimens in PEPFAR-supported countries and the continuous evolution of HIVDR surveillance strategies are essential elements of PEPFAR implementation.
    • Journal Subset:
      Biomedical; Editorial Board Reviewed; Peer Reviewed; USA
    • Instrumentation:
      Impact of Events Scale (IES)
      Global Assessment of Functioning Scale (GAF)
    • ISSN:
      0022-1899
    • MEDLINE Info:
      PMID: NLM29206999 NLM UID: 0413675
    • Publication Date:
      20171222
    • Publication Date:
      20190405
    • DOI:
      http://dx.doi.org/10.1093/infdis/jix432
    • Accession Number:
      126602668
  • Citations
    • ABNT:
      RAIZES, E.; HADER, S.; BIRX, D. Expansion of Viral Load Testing and the Potential Impact on HIV Drug Resistance. Journal of Infectious Diseases, [s. l.], v. 216, p. S805–S807, 2017. DOI 10.1093/infdis/jix432. Disponível em: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=rzh&AN=126602668. Acesso em: 12 ago. 2020.
    • AMA:
      Raizes E, Hader S, Birx D. Expansion of Viral Load Testing and the Potential Impact on HIV Drug Resistance. Journal of Infectious Diseases. 2017;216:S805-S807. doi:10.1093/infdis/jix432
    • APA:
      Raizes, E., Hader, S., & Birx, D. (2017). Expansion of Viral Load Testing and the Potential Impact on HIV Drug Resistance. Journal of Infectious Diseases, 216, S805–S807. https://doi.org/10.1093/infdis/jix432
    • Chicago/Turabian: Author-Date:
      Raizes, Elliot, Shannon Hader, and Deborah Birx. 2017. “Expansion of Viral Load Testing and the Potential Impact on HIV Drug Resistance.” Journal of Infectious Diseases 216 (November): S805–7. doi:10.1093/infdis/jix432.
    • Harvard:
      Raizes, E., Hader, S. and Birx, D. (2017) ‘Expansion of Viral Load Testing and the Potential Impact on HIV Drug Resistance’, Journal of Infectious Diseases, 216, pp. S805–S807. doi: 10.1093/infdis/jix432.
    • Harvard: Australian:
      Raizes, E, Hader, S & Birx, D 2017, ‘Expansion of Viral Load Testing and the Potential Impact on HIV Drug Resistance’, Journal of Infectious Diseases, vol. 216, pp. S805–S807, viewed 12 August 2020, .
    • MLA:
      Raizes, Elliot, et al. “Expansion of Viral Load Testing and the Potential Impact on HIV Drug Resistance.” Journal of Infectious Diseases, vol. 216, Nov. 2017, pp. S805–S807. EBSCOhost, doi:10.1093/infdis/jix432.
    • Chicago/Turabian: Humanities:
      Raizes, Elliot, Shannon Hader, and Deborah Birx. “Expansion of Viral Load Testing and the Potential Impact on HIV Drug Resistance.” Journal of Infectious Diseases 216 (November 16, 2017): S805–7. doi:10.1093/infdis/jix432.
    • Vancouver/ICMJE:
      Raizes E, Hader S, Birx D. Expansion of Viral Load Testing and the Potential Impact on HIV Drug Resistance. Journal of Infectious Diseases [Internet]. 2017 Nov 16 [cited 2020 Aug 12];216:S805–7. Available from: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=rzh&AN=126602668